Skip Navigation

Treatment of Myelodysplastic/ Myeloproliferative Neoplasm, Unclassifiable

For information about the treatments listed below, see the Treatment Option Overview section.

Because myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-UC) is a rare disease, little is known about its treatment. Treatment may include the following:

  • Supportive care treatments to manage problems caused by the disease such as infection, bleeding, and anemia.
  • Targeted therapy (imatinib mesylate).

Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.

This information is not intended to replace the advice of a doctor. Navigating Care disclaims any liability for the decisions you make based on this information. This information was sourced and adapted from Adapted from the National Cancer Institute's Physician Data Query (PDQ®) Cancer Information Summaries on www.cancer.gov.